158 related articles for article (PubMed ID: 15077192)
21. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.
Brandi G; Paiardini M; Cervasi B; Fiorucci C; Filippone P; De Marco C; Zaffaroni N; Magnani M
Cancer Res; 2003 Jul; 63(14):4028-36. PubMed ID: 12874002
[TBL] [Abstract][Full Text] [Related]
22. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
23. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.
Kolluri SK; Weiss C; Koff A; Göttlicher M
Genes Dev; 1999 Jul; 13(13):1742-53. PubMed ID: 10398686
[TBL] [Abstract][Full Text] [Related]
24. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity.
Levine-Fridman A; Chen L; Elferink CJ
Mol Pharmacol; 2004 Feb; 65(2):461-9. PubMed ID: 14742689
[TBL] [Abstract][Full Text] [Related]
26. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.
Jackson DP; Li H; Mitchell KA; Joshi AD; Elferink CJ
Mol Pharmacol; 2014 Apr; 85(4):533-41. PubMed ID: 24431146
[TBL] [Abstract][Full Text] [Related]
27. The cyclin-dependent kinase inhibitor p27
Elson DJ; Nguyen BD; Wood R; Zhang Y; Puig-Sanvicens V; Kolluri SK
FEBS Lett; 2022 Aug; 596(16):2056-2071. PubMed ID: 35735777
[TBL] [Abstract][Full Text] [Related]
28. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin.
Adachi J; Mori Y; Matsui S; Matsuda T
Toxicol Sci; 2004 Jul; 80(1):161-9. PubMed ID: 15056799
[TBL] [Abstract][Full Text] [Related]
29. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract][Full Text] [Related]
30. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
Backlund M; Ingelman-Sundberg M
Mol Pharmacol; 2004 Feb; 65(2):416-25. PubMed ID: 14742684
[TBL] [Abstract][Full Text] [Related]
31. Calpain mediates the dioxin-induced activation and down-regulation of the aryl hydrocarbon receptor.
Dale YR; Eltom SE
Mol Pharmacol; 2006 Nov; 70(5):1481-7. PubMed ID: 16891617
[TBL] [Abstract][Full Text] [Related]
32. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
33. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
[TBL] [Abstract][Full Text] [Related]
34. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
36. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
38. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity.
Oberg M; Bergander L; Håkansson H; Rannug U; Rannug A
Toxicol Sci; 2005 Jun; 85(2):935-43. PubMed ID: 15788723
[TBL] [Abstract][Full Text] [Related]
39. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
40. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
